USA, VitaPath Genetics Raises $6M in Series A Round

VitaPath Genetics, a molecular diagnostics company, closed a $6m series A round of funding led by MDV-Mohr Davidow Ventures.

Foster City-Ca.-based VitaPath was originally seeded by X/Seed Capital, which also co-invested in this round.

The funds will be used to complete the validation of the company’s first assay and prepare for commercial launch.



Join the discussion